Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
MIRA Pharmaceuticals, Inc. (MIRA) has shared an announcement.
Mira Pharmaceuticals, Inc. has undergone a significant board reshuffle to enhance scientific expertise ahead of a future Investigational New Drug Application. After voluntary resignations, new members with strong backgrounds in radiology and marketing joined the board, with the CEO now also serving as Chairman. Additionally, the company has secured the expertise of Dr. Itzchak Angel as Chief Scientific Advisor, leveraging his 30 years of pharmaceutical industry experience to guide the company’s strategic drug development and regulatory affairs.
For an in-depth examination of MIRA stock, go to TipRanks’ Stock Analysis page.